Drug intelligence / Profile preview

ibuprofen + famotidine

Development stage
Approved
Lead developer
Amgen
Modality
Small Molecules
Administration
Oral
01

Overview

**Ibuprofen + famotidine** is an oral fixed-dose combination of ibuprofen 800 mg, a nonselective nonsteroidal anti-inflammatory drug, and famotidine 26.6 mg, a histamine H2-receptor antagonist. Ibuprofen reversibly inhibits cyclooxygenase-1 and cyclooxygenase-2, reducing prostaglandin production and thereby relieving pain and inflammation. Famotidine reduces gastric acid secretion to lower the risk of upper gastrointestinal ulceration associated with chronic high-dose ibuprofen use. It is approved for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis while decreasing the risk of upper gastrointestinal ulcers in patients taking ibuprofen for those conditions.

Brand names
Duexis
Other names
famotidine + ibuprofenibuprofen and famotidineibuprofen/famotidine
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)HRH2 (Histamine H2 Receptor)

Beyond the preview

Go deeper on ibuprofen + famotidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + famotidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call